Several studies suggested that TRIM29 promoted progression of cervical cancer18, pancreatic cancer19, colorectal cancer21, gastric cancer37, and glioma38, while suppressed progression of hepatocellular carcinoma via Wnt/beta-catenin signaling pathway22. This evidence concerns the gene TRIM29 and hepatocellular carcinoma.